Stocks Health care MMED
NASDAQ · Health careMiniMed Group, Inc. (MMED)
It posted a net loss of $314M. In fiscal 2026 capital spending exceeded operating cash flow by $420M. At July 31, 2026 it held $207M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 8, 2026.
What MiniMed Group, Inc. does
MiniMed Group, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker MMED.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $3.1B | -$333M | -$1.30 | -$420M |
| 2026 | $2.7B | -$213M | -$0.84 | -$53M |
| 2024 | $2.5B | -$112M | -$0.44 | -$107M |
Latest SEC filings
What MiniMed Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026
- September 8, 2026Quarterly report 10-Q · period to July 31, 2026
- September 1, 2026
- August 21, 2026
- August 21, 2026Additional proxy material DEFA14A
- August 21, 2026Proxy statement DEF 14A
- August 5, 2026
- June 29, 2026Annual report 10-K · period to April 24, 2026
- June 29, 2026
- June 3, 2026
Questions about MMED
What does MiniMed Group, Inc. do?
MiniMed Group, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker MMED.
Is MiniMed Group, Inc. profitable?
No. Over the twelve months to July 31, 2026 it reported a net loss of $314M.
When did MiniMed Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 8, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the merger registration from September 14, 2026.
Similar companies
Follow MMED
Get an email when MiniMed Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MMED: get an email when it filesWhere the numbers come from
Financial figures are the values MiniMed Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.